微生态制品调节肥胖肠道微生物的研究进展

Abstract
Figure/Table
References (29)
Related Citation (15)

Download: PDF (0 KB) HTML (47 KB)
Export: BibTeX | EndNote (RIS)

Abstract Obesity has become a global epidemic disease that urgently needs to be solved.Studies have shown that obesity is related to the imbalance of intestinal microbiota in the body.The imbalance of intestinal microbiota leads to the disorder of substance and energy metabolism,metabolic endotoxemia,systemic inflammation and insulin resistance in the obese body.Prebiotics can be fermented by intestinal probiotics to produce short-chain fatty acids and other metabolites to improve the diversity and abundance of the intestinal microbiota of the obese body,increase energy consumption,and reduce fat deposition.Meanwhile,short-chain fatty acids can stimulate gastrointestinal hormones of satiety,reduce inflammation,improve insulin resistance,and reduce appetite through the microbiota-gut-brain axis.Prebiotics,probiotics and their derived microecological agents(probiotics,probiotics,synbiotics,postbiotics)have become the hot spot and new strategy for the beneficial treatment of obesity.This research reviews the effect of microbiological products in the treatment of obesity,discusses the related mechanisms,and makes a prospect for its treatment in the future.

Key words： Obesity Gut microbiota Prebiotics Probiotics Sybiotics Postbiotics

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LU Lin-li
	JU Hai-bing

Cite this article:

LU Lin-li,JU Hai-bing. Research progress of microecological agents regulating intestinal microorganism of obesity[J]. 中国当代医药, 2021, 28(26): 51-55.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I26/51

[1]	Kumanyika S，Dietz WH.Solving Population-wide Obesity-Progress and Future Prospects[J].N Engl J Med，2020，383（23）：2197-2200.
[2]	陈烨，范雯，李兰娟，等.中国微生态调节剂临床应用专家共识（2020 版）[J].中华临床感染病杂志，2020，13（4）：241-256.
[3]	Cani PD.Human gut microbiome：hopes，threats and promises[J].Gut，2018，67（9）：1716-1725.
[4]	Qin J，Li R，Raes J，et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature，2010，464（7285）：59-65.
[5]	Gilbert JA，Blaser MJ，Caporaso JG，et al.Current understanding of the human microbiome[J].Nat Med，2018，24（4）：392-400.
[6]	Richard ML，Sokol H.The gut mycobiota：insights into analysis，environmental interactions and role in gastrointestinal diseases[J].Nat Rev Gastroenterol Hepatol，2019，16（6）：331-345.
[7]	Johnson AJ，Vangay P，Al-Ghalith GA，et al.Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans[J].Cell Host Microbe，2019，25（6）：789-802.
[8]	，Ding H，Wang T，et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proc Natl Acad Sci USA，2004，101（44）：15718-15723.
[9]	Turnbaugh PJ，Ley RE，Mahowald MA，et al.An obesity-associated gut microbiome with increased capacity for energy harvest[J].Nature，2006，444（7122）：1027-1031.
[10]	Vallianou N，Stratigou T，Christodoulatos GS，et al.Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders：Current Evidence and Perspectives[J].Curr Obes Rep，2019，8（3）：317-332.
[11]	Canfora EE，Meex RCR，Venema K，et al.Gut microbial metabolites in obesity，NAFLD and T2DM[J].Nat Rev Endocrinol，2019，15（5）：261-273.
[12]	李虹，刘维新.肠道菌群与肥胖相关性的研究进展[J].医学综述，2020，26（17）：3386-3393.
[13]	Vallianou N，Stratigou T，Christodoulatos GS，et al.Probiotics，Prebiotics，Synbiotics，Postbiotics，and Obesity：Current Evidence，Controversies，and Perspectives[J]Curr Obes Rep，2020，9（3）：179-192.
[14]	Delzenne NM，Olivares M，Neyrinck AM，et al.Nutritional interest of dietary fiber and prebiotics in obesity：Lessons from the MyNewGut consortium[J].Clin Nutr，2020，39（2）：414-424.
[15]	Rodriguez J，Hiel S，Neyrinck AM，et al.Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients[J].Gut，2020，69（11）：1975-1987.
[16]	Nicolucci AC，Hume MP，Martínez I，et al.Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity[J].Gastroenterology，2017，153（3）：711-722.
[26]	Anhê FF，Schertzer JD，Marette A.Bacteria to alleviate metabolic syndrome[J].Nat Med，2019，25（7）：1031-1033.
[17]	Salden BN，Troost FJ，Wilms E，et al.Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects：A randomized controlled trial：Arabinoxylans in gut barrier[J].Clin Nutr，2018，37（2）：471-480.
[18]	Michael DR，Jack AA，Masetti G，et al.A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being[J].Sci Rep，2020，10（1）：4183.
[19]	Depommier C，Everard A，Druart C，et al.Supplementation with Akkermansia muciniphila in overweight and obese human volunteers：a proof-of-concept exploratory study[J].Nat Med，2019，25（7）：1096-1103.
[20]	Kang D，Su M，Duan Y，et al.Eurotium cristatum，a potential probiotic fungus from Fuzhuan brick tea，alleviated obesity in mice by modulating gut microbiota[J].Food Funct，2019，10（8）：5032-5045.
[21]	Borgeraas H，Johnson LK，Skattebu J，et al.Effects of probiotics on body weight，body mass index，fat mass and fat percentage in subjects with overweight or obesity：a systematic review and meta-analysis of randomized controlled trials[J].Obes Rev，2018，19（2）：219-232.
[22]	Swanson KS，Gibson GR，Hutkins R，et al.The International Scientific Association for Probiotics and Prebiotics （ISAPP）consensus statement on the definition and scope of synbiotics[J].Nat Rev Gastroenterol Hepatol，2020，17（11）：687-701.
[23]	da Silva TF，Casarotti SN，de Oliveira GLV，et al.The impact of probiotics，prebiotics，and synbiotics on the biochemical，clinical，and immunological markers，as well as on the gut microbiota of obese hosts[J].Crit Rev Food Sci Nutr，2021，61（2）：337-355.
[24]	Krumbeck JA，Rasmussen HE，Hutkins RW，et al.Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics[J].Microbiome，2018，6（1）：121.
[25]	Albillos A，de Gottardi A，Rescigno M.The gut-liver axis in liver disease：Pathophysiological basis for therapy[J].J Hepatol，2020，72（3）：558-577.
[27]	Cerdó T，García-Santos JA，G Bermúdez M，et al.The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity[J].Nutrients，2019，11（3）：635.
[28]	Cani PD，Possemiers S，Van de Wiele T，et al.Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability[J].Gut，2009，58（8）：1091-1103.
[29]	Plovier H，Everard A，Druart C，et al.A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice[J].Nat Med，2017，23（1）：107-113.